Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

AlloVir logo
$0.57 0.00 (-0.02%)
(As of 10:25 AM ET)

Recent AlloVir SEC Filings

DateFilerForm TypeView
11/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
AlloVir (Subject)
Form 425
11/08/2024
3:06 PM
AlloVir (Subject)
Form 425
11/08/2024
3:09 PM
AlloVir (Subject)
Form 425
11/08/2024
3:10 PM
AlloVir (Subject)
Form 425
11/08/2024
7:26 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
AlloVir (Subject)
Form 425
11/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:14 AM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

08/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
8:05 AM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
5:25 PM
AlloVir (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
07/23/2024
3:25 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:27 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:28 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:28 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:10 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:24 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2024
3:35 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:33 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:33 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:35 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:00 PM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2024
3:05 PM
AlloVir (Filer)
Form DEF 14A
04/23/2024
3:06 PM
AlloVir (Filer)
Form DEFA14A
04/23/2024
3:08 PM
AlloVir (Filer)
Form ARS
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
04/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners